The presence of underlying asthma should be investigated in patients diagnosed with ACE inhibitor induced cough.
İnsu YılmazMurat TurkBurcu Baran KetencioğluZeki ÇetinkayaNuri TutarFatma Sema Oymakİnci GülmezNewton Franklin AdkinsonPublished in: The clinical respiratory journal (2020)
Asthma and an atopic background constitute a substantial risk factor for ACE-I induced cough. The presence of underlying asthma should be investigated in patients diagnosed with ACE inhibitor induced cough. However, the fact that most asthma patients tolerate ACE-I therapy, indicates that other cofactors are likely involved.
Keyphrases
- end stage renal disease
- chronic obstructive pulmonary disease
- newly diagnosed
- ejection fraction
- chronic kidney disease
- angiotensin ii
- lung function
- peritoneal dialysis
- high glucose
- angiotensin converting enzyme
- oxidative stress
- cystic fibrosis
- mesenchymal stem cells
- bone marrow
- patient reported outcomes
- endothelial cells
- air pollution
- high resolution
- cell therapy